HIBICLENS Drug Patent Profile

✉ Email this page to a colleague

When do Hibiclens patents expire, and when can generic versions of Hibiclens launch?

Hibiclens is a drug marketed by Molnlycke Hlth and is included in two NDAs.

The generic ingredient in HIBICLENS is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Hibiclens

A generic version of HIBICLENS was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24^th, 1989.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for HIBICLENS?
What are the global sales for HIBICLENS?
What is Average Wholesale Price for HIBICLENS?

Summary for HIBICLENS

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	42
Clinical Trials:	15
Patent Applications:	6,899
Drug Sales Revenues:	Drug sales revenues for HIBICLENS
What excipients (inactive ingredients) are in HIBICLENS?	HIBICLENS excipients list
DailyMed Link:	HIBICLENS at DailyMed

Drug patent expirations by year for HIBICLENS

Recent Clinical Trials for HIBICLENS

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Yaneve Fonge	Phase 4
University of Missouri-Columbia	Phase 4
Carilion Clinic	Phase 4

See all HIBICLENS clinical trials

Pharmacology for HIBICLENS

Physiological Effect	Decreased Cell Wall Integrity

US Patents and Regulatory Information for HIBICLENS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Molnlycke Hlth	HIBICLENS	chlorhexidine gluconate	SOLUTION;TOPICAL	017768-001	Approved Prior to Jan 1, 1982		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Molnlycke Hlth	HIBICLENS	chlorhexidine gluconate	SPONGE;TOPICAL	018423-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for HIBICLENS

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Molnlycke Hlth	HIBICLENS	chlorhexidine gluconate	SOLUTION;TOPICAL	017768-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Molnlycke Hlth	HIBICLENS	chlorhexidine gluconate	SPONGE;TOPICAL	018423-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Molnlycke Hlth	HIBICLENS	chlorhexidine gluconate	SPONGE;TOPICAL	018423-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Molnlycke Hlth	HIBICLENS	chlorhexidine gluconate	SPONGE;TOPICAL	018423-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Molnlycke Hlth	HIBICLENS	chlorhexidine gluconate	SOLUTION;TOPICAL	017768-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for HIBICLENS

See the table below for patents covering HIBICLENS around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
United Kingdom	1338003		⤷ Sign Up
Belgium	710394		⤷ Sign Up
Switzerland	495749	Mittel zur Beseitigung von Schuppen auf der Kopfhaut	⤷ Sign Up
Malaysia	7400297	CLEANSING COMPOSITIONS	⤷ Sign Up
Netherlands	167852		⤷ Sign Up
Belgium	785049		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for HIBICLENS

Recent Clinical Trials for HIBICLENS

Pharmacology for HIBICLENS

Make Better Decisions: Try a trial or see plans & pricing